These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8265721)

  • 1. Pharmacokinetics and irreversible binding of tolmetin and its glucuronic acid esters in the elderly.
    Munafo A; Hyneck ML; Benet LZ
    Pharmacology; 1993 Nov; 47(5):309-17. PubMed ID: 8265721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and irreversible plasma protein binding of tolmetin in humans.
    Hyneck ML; Smith PC; Munafo A; McDonagh AF; Benet LZ
    Clin Pharmacol Ther; 1988 Jul; 44(1):107-14. PubMed ID: 3390998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro.
    Munafo A; McDonagh AF; Smith PC; Benet LZ
    Pharm Res; 1990 Jan; 7(1):21-7. PubMed ID: 2300531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    J Pharmacokinet Biopharm; 1994 Feb; 22(1):19-40. PubMed ID: 8027947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible binding of tolmetin to macromolecules via its glucuronide: binding to blood constituents, tissue homogenates and subcellular fractions in vitro.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    Xenobiotica; 1994 Jun; 24(6):495-506. PubMed ID: 7975715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible binding of zomepirac to plasma protein in vitro and in vivo.
    Smith PC; McDonagh AF; Benet LZ
    J Clin Invest; 1986 Mar; 77(3):934-9. PubMed ID: 3949982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of experimental hypoalbuminemia on the plasma protein binding of tolmetin.
    Pérez-Urizar J; Flores-Murrieta FJ; Castañeda-Hernández G
    Life Sci; 2002 Jul; 71(9):1015-22. PubMed ID: 12088761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry.
    Ding A; Ojingwa JC; McDonagh AF; Burlingame AL; Benet LZ
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3797-801. PubMed ID: 8483897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism.
    Smith PC; Benet LZ; McDonagh AF
    Drug Metab Dispos; 1990; 18(5):639-44. PubMed ID: 1981713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies By tandem mass spectrometry.
    Qiu Y; Burlingame AL; Benet LZ
    Drug Metab Dispos; 1998 Mar; 26(3):246-56. PubMed ID: 9492388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry.
    Ding A; Zia-Amirhosseini P; McDonagh AF; Burlingame AL; Benet LZ
    Drug Metab Dispos; 1995 Mar; 23(3):369-76. PubMed ID: 7628303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein.
    Volland C; Sun H; Dammeyer J; Benet LZ
    Drug Metab Dispos; 1991; 19(6):1080-6. PubMed ID: 1687014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of zomepirac sodium in man.
    O'Neill PJ; Yorgey KA; Renzi NL; Williams RL; Benet LZ
    J Clin Pharmacol; 1982 Oct; 22(10):470-6. PubMed ID: 7174855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac.
    Smith PC; Langendijk PN; Bosso JA; Benet LZ
    Clin Pharmacol Ther; 1985 Aug; 38(2):121-7. PubMed ID: 3874742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear and nonlinear assessment of tolmetin pharmacokinetics.
    Ayres JW; Weidler DJ; Sakmar E; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):583-93. PubMed ID: 897347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide.
    Sallustio BC; Fairchild BA; Pannall PR
    Drug Metab Dispos; 1997 Jan; 25(1):55-60. PubMed ID: 9010630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing.
    Zia-Amirhosseini P; Ojingwa JC; Spahn-Langguth H; McDonagh AF; Benet LZ
    Clin Pharmacol Ther; 1994 Jan; 55(1):21-7. PubMed ID: 8299313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo irreversible plasma protein binding of beclobric acid enantiomers.
    Mayer S; Mutschler E; Benet LZ; Sphahn-Langguth H
    Chirality; 1993; 5(3):120-5. PubMed ID: 8338721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of gemfibrozil 1-o-beta-acyl glucuronide. Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats.
    Sallustio BC; Foster DJ
    Drug Metab Dispos; 1995 Sep; 23(9):892-9. PubMed ID: 8565777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and mass-spectrometric characterization of human serum albumins modified by covalent binding of two non-steroidal anti-inflammatory drugs: tolmetin and zomepirac.
    Zia-Amirhosseini P; Ding A; Burlingame AL; McDonagh AF; Benet LZ
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):431-5. PubMed ID: 7487878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.